Senior insider sale
PMV PHARMACEUTICALS, INC. — senior position signals high conviction
$3.65M
2.28M shares
What this filing means
ORBIMED ADVISORS LLC plans to sell 2.28M shares of PMV PHARMACEUTICALS, INC. valued at approximately $3.65M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/10/2025ACC: 0000947871-25-000847
Director10% Owner
Since Sep 2020
2.28M
Shares to sell
$3.65M
Approx. market value
2.28M
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Initial Public Offering
Cash
9/29/2020
2.28MTotal acquired2.28M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/29/2020 | Initial Public Offering Cash | 2.28M | — |
| Total | 2.28M | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.28M
Market value
$3.65M
9/10/2025
Total
Units
2.28M
Value
$3.65M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/10/2025 | 2.28M | $3.65M | NASDAQ | Planned |
| Total | 2.28M | $3.65M | ||